메뉴 건너뛰기




Volumn 17, Issue 4, 2010, Pages 48-50

Maintenance ketamine treatment produces long-term recovery from depression

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

EID: 77951706858     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (21)

References (12)
  • 1
    • 0028243389 scopus 로고
    • Definition and differential diagnosis of treatment-resistant depression
    • Burrows GD, Norman TR, Judd FK. Definition and differential diagnosis of treatment-resistant depression. Int Clin Psychopharmacol. 1994;9(suppl 2):5-10.
    • (1994) Int Clin Psychopharmacol , vol.9 , Issue.SUPPL. 2 , pp. 5-10
    • Burrows, G.D.1    Norman, T.R.2    Judd, F.K.3
  • 2
    • 0034934419 scopus 로고    scopus 로고
    • The burden of disease for treatment-resistant depression
    • Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):26-31.
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 16 , pp. 26-31
    • Greden, J.F.1
  • 3
    • 0033969685 scopus 로고    scopus 로고
    • Antidepressant effects of ketamine in depressed patients
    • Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351-354.
    • (2000) Biol Psychiatry , vol.47 , Issue.4 , pp. 351-354
    • Berman, R.M.1    Cappiello, A.2    Anand, A.3
  • 4
    • 33746896935 scopus 로고    scopus 로고
    • A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
    • Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856-864.
    • (2006) Arch Gen Psychiatry , vol.63 , Issue.8 , pp. 856-864
    • Zarate Jr., C.A.1    Singh, J.B.2    Carlson, P.J.3
  • 6
    • 77951720387 scopus 로고    scopus 로고
    • Metropolitan Life Insurance Company, Available at, Accessed February 23
    • Metropolitan Life Insurance Company. Weight Charts. Available at: www.coping.org/weightmgt/strategies/Weight%20Charts.doc. Accessed February 23, 2010.
    • (2010) Weight Charts
  • 7
    • 34548773850 scopus 로고    scopus 로고
    • What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials
    • Berlim MT, Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007;17(11):696-707.
    • (2007) Eur Neuropsychopharmacol , vol.17 , Issue.11 , pp. 696-707
    • Berlim, M.T.1    Turecki, G.2
  • 8
    • 21344471669 scopus 로고    scopus 로고
    • Antidepressant effect of ketamine during ECT
    • Ostroff R, Gonzalis M, Sanacora G. Antidepressant effect of ketamine during ECT. Am J Psychiatry. 2005;162(7):1385-1386.
    • (2005) Am J Psychiatry , vol.162 , Issue.7 , pp. 1385-1386
    • Ostroff, R.1    Gonzalis, M.2    Sanacora, G.3
  • 9
    • 77951733467 scopus 로고    scopus 로고
    • Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: Comparing ketamine and propofol anesthesia
    • November 19, Epub ahead of print
    • Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: Comparing ketamine and propofol anesthesia. J ECT. November 19, 2009 [Epub ahead of print].
    • (2009) J ECT
    • Okamoto, N.1    Nakai, T.2    Sakamoto, K.3    Nagafusa, Y.4    Higuchi, T.5    Nishikawa, T.6
  • 10
    • 0346461630 scopus 로고    scopus 로고
    • Glutamate and depression: Clinical and preclinical studies
    • Paul IA, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci. 2003;1003:250-272.
    • (2003) Ann N Y Acad Sci , vol.1003 , pp. 250-272
    • Paul, I.A.1    Skolnick, P.2
  • 11
    • 42349089786 scopus 로고    scopus 로고
    • Intravenous ketamine for treatment-resistant major depressive disorder
    • Rot M, Chaney D, Mathew S. Intravenous ketamine for treatment-resistant major depressive disorder. Primary Psychiatry. 2008;15(4):39-47.
    • (2008) Primary Psychiatry , vol.15 , Issue.4 , pp. 39-47
    • Rot, M.1    Chaney, D.2    Mathew, S.3
  • 12
    • 0347722453 scopus 로고    scopus 로고
    • Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: Role of the glutamatergic system
    • Zarate CA Jr, Du J, Quiroz J, et al. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci. 2003;1003:273-291.
    • (2003) Ann N Y Acad Sci , vol.1003 , pp. 273-291
    • Zarate Jr., C.A.1    Du, J.2    Quiroz, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.